[url=http://www.msnbc.msn.com/id/24015019/]Heparin probe reveals global drug market perils
Contaminated blood thinner raises fears about offshore production
CHANGZHOU, China - On a dusty lane in east China, a small factory sitting amid strawberry and vegetable fields processes chemicals from pig guts into heparin, a commonly used blood thinner linked to 62 deaths and hundreds of allergic reactions in the U.S. and Germany.
The mysterious problems with heparin from the factory and others like it — China’s deadliest product quality scandal since Chinese cough syrup killed 93 people in Central America a year ago — dramatically illustrate the perils of shifting drug production offshore.
One more example of Big Pharma's greed and the American people's willingness to accept it.
The U.S. FDA inspects only about 7 percent of foreign drug makers each year; it failed to inspect Changzhou SPL because of what it says was a language mistake.